About BioProtect
BioProtect is a Healthcare company based in Kochav Yair Tzur Yigal (Israel) founded in 2001 by Shaul Shohat and Adrian Paz, and was acquired by Olympus in May 2026. Radiation protection technology is developed for prostate cancer radiotherapy. BioProtect has raised $74.1 million across 10 funding rounds from investors including Medtronic, Olympus and European Union. BioProtect offers products and services including BioProtect Balloon Implant System. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its legal entity is BIOPROTECT MEDICAL INC.
Company details
BioProtect was founded in 2001 as a developer of radiation protection solutions in the medical technology sector. The BioProtectProSpace Balloon System has been created to serve as a spacer, displacing healthy tissue from high-dose radiation areas during prostate cancer treatments. Operations focus on advancing radiotherapy accessories, with co-founders Shaul Shohat as CTO and Adrian Paz leading the efforts. No specific geographic base is indicated.
Products & Services of BioProtect
BioProtect offers a comprehensive portfolio of products and services, including BioProtect Balloon Implant System.
Biodegradable balloon for spacing rectal wall during prostate radiotherapy.
Apps and channels of BioProtect
its YouTube channel BioProtect has 5 subscribers.
Funding Insights of BioProtect
BioProtect has successfully raised a total of $74.1M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $2.65 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $74.1M
- Total Rounds 10
- Last Round Grant β $2.65M
- First Round $500,000
(Oct 2004)
- Investors Count 11
All 10 funding rounds of BioProtect with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $2.65M | Grant | β | β | |
| Sep 2023 | $28M | Series E | β | MVM | |
| Sep 2020 | $25M | Series D | β | Vincent Tchenguiz, Almeda Ventures | |
| Jan 2020 | $13M | Series D | β | KB Investment, Accelmed Ventures | β |
| Apr 2017 | $3.5M | Series A | β | β | β |
| Sep 2011 | $700,000 | Seed | β | Xenia Venture Capital | β |
| Jul 2010 | $750,000 | Seed | β | β | β |
| Jun 2008 | $1.65M | Seed | β | Xenia Venture Capital | β |
| Feb 2007 | $1M | Seed | β | Xenia Venture Capital | β |
| Oct 2004 | $500,000 | Seed | β | Xenia Venture Capital | β |
12 investors in total: 11 institutional and 1 angel.
Investors in BioProtect
BioProtect has secured backing from 12 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Medtronic, Olympus and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Peregrine is focused on healthcare innovation through strategic global investments. | peregrinevc.com | Or Yehuda, Israel | ||
Venture capital fund investing in early-stage tech startups | 1990 | kbic.co.kr | Seoul, South Korea | |
Investments in health tech sectors are managed by Almeda Ventures. | almedaventures.com | Tel Aviv, Israel | ||
Venture capital firm investing in early stage healthcare startups | triventures.vc | Herzliya, Israel | ||
| accelmed-ventures.com | ||||
Early-stage centric life sciences and tech focused VC firm investing primarily in Israel and the US | 2003 | xenia.co.il | Tel Aviv, Israel | |
| mvm.com | ||||
| cbg.uk.com | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States |
Investor details for BioProtect
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioProtect
21 people are tracked at BioProtect (9 in leadership, 5 in board & advisors, 7 in team).
| Name | Role | Group |
|---|---|---|
Shaul Shohat | Co-Founder & CTO | Leadership |
Adrian Paz | Co-Founder | Leadership |
Itay Barnea | CEO At Bioprotect | Leadership |
Lee Adler | Chief Operating Officer | Leadership |
Shahar Shaked | VP Finance & Administration | Leadership |
Udi Wexler | Director Of Engineering | Leadership |
Derek Webster | Senior Vice President Of Sales | Leadership |
Arik Tzour, PhD., MBA | Clinical Director | Leadership |
Dafna Carmi-Yinon | VP, Clinical Affairs | Leadership |
Michal Geva | Board Member | Board & advisors |
Merav Kaye | Board Member | Board & advisors |
Eyal Lifshitz | Board Member | Board & advisors |
Gennadiy Tolstobrov | Board Member | Board & advisors |
Irit Yaniv | Board Member | Board & advisors |
Ofer Weis | Supply Chain Manager | Team |
Ami Jackson | Human Resources Manager | Team |
Dr. med. Monika Hess | Territory Manager - Germany | Team |
Esti Diskin | Clinical Engineer | Team |
Brittany Stokes | Sales Manager | Team |
Joel Hix | North Texas Sales Manager | Team |
1 more people are available in the full profile.
Complete people profiles for BioProtect
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioProtect
4 dated milestones of BioProtect across 25 years, from founding to its latest funding, stage changes and deals.
- Founded BioProtect is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Grant, of $2.6M.
- Exit Acquired by Olympus.
Top companies in Imaging Diagnostics
2 companies that operate in the same segment as BioProtect (Imaging Diagnostics) in Israel, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | 541 | ||
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioprotect
Complete news archive for BioProtect
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioProtect
BioProtect was founded in 2001 and raised its 1st funding round 3 years after it was founded.
BioProtect is headquartered in Kochav Yair Tzur Yigal, Israel.
BioProtect is a funded company, having raised a total of $74.1M across 10 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Oct 2004.
BioProtect was founded in 2001 as a developer of radiation protection solutions in the medical technology sector. The BioProtectProSpace Balloon System has been created to serve as a spacer, displacing healthy tissue from high-dose radiation areas during prostate cancer treatments. Operations focus on advancing radiotherapy accessories, with co-founders Shaul Shohat as CTO and Adrian Paz leading the efforts. No specific geographic base is indicated.
BioProtect offers BioProtect Balloon Implant System.
BioProtect has 12 investors. Key investors include Medtronic, Olympus, European Union, KB Investment, and Xenia Venture Capital.
BioProtect operates through Bioprotect Medical Inc.
Yes. BioProtect was acquired by Olympus in May 2026.

